AU2001287396A1 - Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature - Google Patents
Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired featureInfo
- Publication number
- AU2001287396A1 AU2001287396A1 AU2001287396A AU8739601A AU2001287396A1 AU 2001287396 A1 AU2001287396 A1 AU 2001287396A1 AU 2001287396 A AU2001287396 A AU 2001287396A AU 8739601 A AU8739601 A AU 8739601A AU 2001287396 A1 AU2001287396 A1 AU 2001287396A1
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- kits
- selecting
- methods
- desired feature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36141—Use of virus, viral particle or viral elements as a vector
- C12N2770/36143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/641,931 US6830885B1 (en) | 2000-08-18 | 2000-08-18 | Nucleic acid molecule, method and kit for selecting a nucleic acid having a desired feature |
US09/641,931 | 2000-08-18 | ||
PCT/CA2001/001169 WO2002016572A2 (en) | 2000-08-18 | 2001-08-17 | Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001287396A1 true AU2001287396A1 (en) | 2002-03-04 |
Family
ID=24574457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001287396A Abandoned AU2001287396A1 (en) | 2000-08-18 | 2001-08-17 | Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature |
Country Status (5)
Country | Link |
---|---|
US (1) | US6830885B1 (en) |
EP (1) | EP1322754A2 (en) |
AU (1) | AU2001287396A1 (en) |
CA (1) | CA2418097A1 (en) |
WO (1) | WO2002016572A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1402020A2 (en) * | 2001-06-28 | 2004-03-31 | Phenogene Therapeutiques Inc. | Methods, vectors, cell lines and kits for selecting nucleic acids having a desired feature |
EP3404102B1 (en) | 2004-04-21 | 2021-08-11 | Alexion Pharmaceuticals, Inc. | Bone delivery conjugates and method of using same to target proteins to bone |
TWI615403B (en) * | 2007-02-21 | 2018-02-21 | 腫瘤療法 科學股份有限公司 | Peptide vaccines for cancers expressing tumor-associated antigens |
TW201008574A (en) | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
US9266939B2 (en) | 2010-12-27 | 2016-02-23 | Alexion Pharmaceuticals, Inc. | Compositions comprising natriuretic peptides and methods of use thereof |
US10052366B2 (en) | 2012-05-21 | 2018-08-21 | Alexion Pharmaceuticsl, Inc. | Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
US10822596B2 (en) | 2014-07-11 | 2020-11-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for treating craniosynostosis |
AU2015357551B2 (en) | 2014-12-05 | 2021-02-25 | Alexion Pharmaceuticals, Inc. | Treating seizure with recombinant alkaline phosphatase |
CA2973883A1 (en) | 2015-01-28 | 2016-08-04 | Alexion Pharmaceuticals, Inc. | Methods of treating a subject with an alkaline phosphatase deficiency |
EP3337894A1 (en) | 2015-08-17 | 2018-06-27 | Alexion Pharmaceuticals, Inc. | Manufacturing of alkaline phosphatases |
EP3355904A4 (en) | 2015-09-28 | 2019-06-12 | Alexion Pharmaceuticals, Inc. | Identifying effective dosage regimens for tissue non-specific alkaline phosphatase (tnsalp)-enzyme replacement therapy of hypophosphatasia |
EP3368062A4 (en) | 2015-10-30 | 2019-07-03 | Alexion Pharmaceuticals, Inc. | Methods for treating craniosynostosis in a patient |
US11065306B2 (en) | 2016-03-08 | 2021-07-20 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in children |
US10898549B2 (en) | 2016-04-01 | 2021-01-26 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in adolescents and adults |
MX2018011833A (en) | 2016-04-01 | 2019-02-13 | Alexion Pharma Inc | Treating muscle weakness with alkaline phosphatases. |
WO2017214130A1 (en) | 2016-06-06 | 2017-12-14 | Alexion Pharmaceuticals, Inc. | Metal impact on manufacturing of alkaline phosphatases |
US11116821B2 (en) | 2016-08-18 | 2021-09-14 | Alexion Pharmaceuticals, Inc. | Methods for treating tracheobronchomalacia |
CA3057502A1 (en) | 2017-03-31 | 2018-10-04 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia (hpp) in adults and adolescents |
JP2021519590A (en) | 2018-03-30 | 2021-08-12 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | Glycoprotein production |
US20220003777A1 (en) * | 2018-11-08 | 2022-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods Employing Mucin-Specific Proteases |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5217879A (en) * | 1989-01-12 | 1993-06-08 | Washington University | Infectious Sindbis virus vectors |
JP2000505306A (en) | 1996-02-26 | 2000-05-09 | モルフォシス・アクチェンゲゼルシャフト | Novel method for identifying nucleic acid sequences encoding two or more interacting (poly) peptides |
US6197502B1 (en) | 1997-11-17 | 2001-03-06 | Cytos Biotechnology Ag | Expression cloning processes for the discovery characterization, and isolation of genes encoding polypeptides with a predetermined property |
AU761367B2 (en) | 1998-01-16 | 2003-06-05 | Large Scale Biology Corporation | Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host |
US6150098A (en) * | 1998-02-20 | 2000-11-21 | Amgen Inc. | Methods for identifying novel secreted mammalian polypeptides |
-
2000
- 2000-08-18 US US09/641,931 patent/US6830885B1/en not_active Expired - Lifetime
-
2001
- 2001-08-17 EP EP01966851A patent/EP1322754A2/en not_active Withdrawn
- 2001-08-17 WO PCT/CA2001/001169 patent/WO2002016572A2/en active Application Filing
- 2001-08-17 CA CA002418097A patent/CA2418097A1/en not_active Abandoned
- 2001-08-17 AU AU2001287396A patent/AU2001287396A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6830885B1 (en) | 2004-12-14 |
WO2002016572A2 (en) | 2002-02-28 |
CA2418097A1 (en) | 2002-02-28 |
EP1322754A2 (en) | 2003-07-02 |
WO2002016572A3 (en) | 2003-05-01 |
WO2002016572A9 (en) | 2003-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001287396A1 (en) | Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature | |
AU2001268513A1 (en) | Nucleic acid accessible hybridization sites | |
AU2002217904A1 (en) | Methods for efficiently minig broad data sets for biological markers | |
AU2002225888A1 (en) | Double transposition methods for manipulating nucleic acids | |
AUPQ968300A0 (en) | Chemical methods | |
AU2627201A (en) | Methods and reagents for facilitating transcription | |
AU4028800A (en) | Method for identifying accessible binding sites on rna | |
AU2001234455A1 (en) | Informative nucleic acid arrays and methods for making same | |
AU2001244609A1 (en) | Novel protein, dna thereof and process for producing the same | |
AU2001229576A1 (en) | Nucleic acid binding site assay and selection method | |
AU2002367943A1 (en) | Improved reagents and methods for producing parvoviruses | |
AU2001269109A1 (en) | Single molecule sequencing method | |
AU2001293035A1 (en) | Hydrocracking process | |
AU2001290623A1 (en) | Interbank process | |
AU2001249170A1 (en) | Method for modifying a nucleic acid | |
AU2002218440A1 (en) | New process | |
AU2001268514A1 (en) | Method for screening dna binding | |
AU2001252390A1 (en) | Nucleic acid immunization | |
AU2001294907A1 (en) | Process for imparting corrosion resistance | |
AU2001241853A1 (en) | A method of reconstituting nucleic acid molecules | |
AU2001235282A1 (en) | Circular extra-chromosomal dna elements | |
AU4764900A (en) | Method for inserting a nucleic acid fragment in a vector, uses thereof and kits therefor | |
AU2001242507A1 (en) | Method, diagnostic kit and microarray for determining the rhesus factor | |
AU2001271913A1 (en) | Process guru | |
AU2001264117A1 (en) | Chemical process |